JP2023523872A5 - - Google Patents

Info

Publication number
JP2023523872A5
JP2023523872A5 JP2021577862A JP2021577862A JP2023523872A5 JP 2023523872 A5 JP2023523872 A5 JP 2023523872A5 JP 2021577862 A JP2021577862 A JP 2021577862A JP 2021577862 A JP2021577862 A JP 2021577862A JP 2023523872 A5 JP2023523872 A5 JP 2023523872A5
Authority
JP
Japan
Prior art keywords
anamycin
liposomal
bag
vial
vials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021577862A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023523872A (ja
JP7830131B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/039621 external-priority patent/WO2020264161A1/en
Publication of JP2023523872A publication Critical patent/JP2023523872A/ja
Publication of JP2023523872A5 publication Critical patent/JP2023523872A5/ja
Application granted granted Critical
Publication of JP7830131B2 publication Critical patent/JP7830131B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021577862A 2019-06-28 2020-06-25 リポソーム化アナマイシンを再構成する方法 Active JP7830131B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962868190P 2019-06-28 2019-06-28
US62/868,190 2019-06-28
PCT/US2020/039621 WO2020264161A1 (en) 2019-06-28 2020-06-25 Method of reconstituting liposomal annamycin

Publications (3)

Publication Number Publication Date
JP2023523872A JP2023523872A (ja) 2023-06-08
JP2023523872A5 true JP2023523872A5 (https=) 2023-07-14
JP7830131B2 JP7830131B2 (ja) 2026-03-16

Family

ID=74061076

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021577862A Active JP7830131B2 (ja) 2019-06-28 2020-06-25 リポソーム化アナマイシンを再構成する方法

Country Status (15)

Country Link
US (2) US12257262B2 (https=)
EP (1) EP3990041B1 (https=)
JP (1) JP7830131B2 (https=)
KR (1) KR20220027941A (https=)
CN (2) CN114728101B (https=)
AU (2) AU2020302784A1 (https=)
BR (1) BR112021026480A2 (https=)
CA (1) CA3144443A1 (https=)
ES (1) ES3049663T3 (https=)
IL (1) IL289433B1 (https=)
MX (1) MX2021015667A (https=)
PL (1) PL3990041T3 (https=)
SG (1) SG11202113005SA (https=)
TW (2) TWI857086B (https=)
WO (1) WO2020264161A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2021015668A (es) 2019-06-28 2022-04-18 Univ Texas Preparacion de un liofilizado de anamicina preliposomica.
BR112021026480A2 (pt) 2019-06-28 2022-02-08 Univ Texas Método para reconstituir anamicina, método para preparar uma dose eficaz de uma formulação lipossômica reconstituída de anamicina e método para tratar câncer
EP4061810A4 (en) * 2019-11-21 2023-12-20 Board of Regents, The University of Texas System Lung targeted anticancer therapies with liposomal annamycin

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927571A (en) * 1987-05-18 1990-05-22 Liposome Technology, Inc. Preparation of injectable doxorubicin/liposome suspension
US4863739A (en) 1987-05-19 1989-09-05 Board Of Regents, The University Of Texas System Liposome compositions of anthracycline derivatives
IS1685B (is) * 1990-12-11 1998-02-24 Bracco International B.V. Aðferð við að búa til fitukúlur (liposomes) sem eru gæddar auknum hæfileika til að draga í sig og halda í sér aðskotaefnum
US5902604A (en) * 1995-06-06 1999-05-11 Board Of Regents, The University Of Texas System Submicron liposome suspensions obtained from preliposome lyophilizates
WO2001032145A1 (en) 1999-10-29 2001-05-10 Board Of Regents, The University Of Texas System Method of cancer treatment
TWI433693B (zh) * 2003-02-14 2014-04-11 Childrens Hosp & Res Ct Oak 親脂藥物傳送媒介物及其使用方法
ES2637072T3 (es) * 2010-03-10 2017-10-10 Cempra Pharmaceuticals, Inc. Formulación parenteral de antibióticos macrólidos
IL301603A (en) * 2011-10-14 2023-05-01 Genentech Inc Pertuzumab, trastuzumab, docetaxel and carboplatin for use in the preoperative treatment of a patient
SI2768484T1 (sl) * 2011-10-21 2019-12-31 Jazz Pharmaceuticals Research Llc Liofilizirani liposomi
US8926994B2 (en) 2011-12-07 2015-01-06 The Methodist Hospital Research Institute Mesoporous silicon particles for the presentation of tumor antigens and adjuvant for anti-cancer immunity
KR20170060042A (ko) 2014-09-13 2017-05-31 노파르티스 아게 Alk 억제제의 조합 요법
KR20170066546A (ko) 2014-10-03 2017-06-14 노파르티스 아게 조합 요법
CN107569508A (zh) * 2016-07-05 2018-01-12 江苏竞诺择生物医药科技有限公司 一种治疗造血系统增殖性疾病的药用组合物
KR20190067172A (ko) 2016-09-09 2019-06-14 아이리시스, 인크. 리포좀 항암 조성물
WO2019023873A1 (zh) * 2017-07-31 2019-02-07 江苏竞诺择生物医药科技有限公司 一种用于治疗造血系统增殖性疾病的纳米脂质微粒组合物及药用组合物
CN112955145A (zh) 2018-09-04 2021-06-11 密涅瓦神经科学有限公司 使用苯氧丙胺化合物治疗疼痛的方法
BR112021026480A2 (pt) 2019-06-28 2022-02-08 Univ Texas Método para reconstituir anamicina, método para preparar uma dose eficaz de uma formulação lipossômica reconstituída de anamicina e método para tratar câncer
MX2021015668A (es) 2019-06-28 2022-04-18 Univ Texas Preparacion de un liofilizado de anamicina preliposomica.
EP4061810A4 (en) 2019-11-21 2023-12-20 Board of Regents, The University of Texas System Lung targeted anticancer therapies with liposomal annamycin

Similar Documents

Publication Publication Date Title
JP2023523872A5 (https=)
JP6159567B2 (ja) 既製のゲムシタビン注入溶液
WO1999039694A2 (en) Compositions containing organic compounds
AU2024203593B2 (en) Method of reconstituting liposomal annamycin
US20240189234A1 (en) Silicon particles for drug delivery
CN104971049B (zh) 一种含有福沙匹坦的冻干制剂及其制备方法
WO2020010616A1 (zh) 用于内镜手术的组合
CN103877013A (zh) 一种细辛脑注射剂及其制备方法
WO2011082369A2 (en) Injectable formulations for parenteral administration
CN104958269B (zh) 一种兰索拉唑冻干乳剂及其制备方法
WO2024079565A1 (en) Stable mitomycin concentrates